Skip to main content

US ClosedU.S. Closed

TNYA: Tenaya Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Tenaya Therapeutics, Inc. , a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

52W Range

9thpctl

Volume

0.35×avg

Market Cap

149.75MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Tenaya Therapeutics, Inc.

TNYANASDAQ·USD·Closed

Tenaya Therapeutics, Inc.

TNYANASDAQ·USD·Closed

$0.69

−0.73%

$0.69

−$0.01 (0.73%)

52W Range

9thpctl

Volume

0.35×avg

Mkt Cap

149.75MUSD

P/E

-1.3TTM

Div Yield

–ann